Gian Gandhi1. 1. United Nations Children's Fund, New York, USA. ggandhi@unicef.org.
Abstract
BACKGROUND: GAVI's focus on reducing inequities in access to vaccines, immunization, and GAVI funds, - both between and within countries - has changed over time. This paper charts that evolution. METHODS: A systematic qualitative review was conducted by searching PubMed, Google Scholar and direct review of available GAVI Board papers, policies, and program guidelines. Documents were included if they described or evaluated GAVI policies, strategies, or programs and discussed equity of access to vaccines, utilization of immunization services, or GAVI funds in countries currently or previously eligible for GAVI support. Findings were grouped thematically, categorized into time periods covering GAVI's phases of operations, and assessed depending on whether the approaches mediated equity of opportunity or equity of outcomes between or within countries. RESULTS: Serches yielded 2816 documents for assessment. After pre-screening and removal of duplicates, 552 documents underwent detailed evaluation and pertinent information was extracted from 188 unique documents. As a global funding mechanism, GAVI responded rationally to a semi-fixed funding constraint by focusing on between-country equity in allocation of resources. GAVI's predominant focus and documented successes have been in addressing between-country inequities in access to vaccines comparing lower income (GAVI-eligible) countries with higher income (ineligible) countries. GAVI has had mixed results at addressing between-country inequities in utilization of immunization services, and has only more recently put greater emphasis and resources towards addressing within-country inequities in utilization to immunization services. Over time, GAVI has progressively added vaccines to its portfolio. This expansion should have addressed inter-country, inter-regional, inter-generational and gender inequities in disease burden, however, evidence is scant with respect to final outcomes. CONCLUSION: In its next phase of operations, the Alliance can continue to demonstrate its strength as a highly effective multi-partner enterprise, capable of learning and innovating in a world that has changed much since its inception. By building on its successes, developing more coherent and consistent approaches to address inequities between and within countries and by monitoring progress and outcomes, GAVI is well-positioned to bring the benefits of vaccination to previously unreached and underserved communities towards provision of universal health coverage.
BACKGROUND:GAVI's focus on reducing inequities in access to vaccines, immunization, and GAVI funds, - both between and within countries - has changed over time. This paper charts that evolution. METHODS: A systematic qualitative review was conducted by searching PubMed, Google Scholar and direct review of available GAVI Board papers, policies, and program guidelines. Documents were included if they described or evaluated GAVI policies, strategies, or programs and discussed equity of access to vaccines, utilization of immunization services, or GAVI funds in countries currently or previously eligible for GAVI support. Findings were grouped thematically, categorized into time periods covering GAVI's phases of operations, and assessed depending on whether the approaches mediated equity of opportunity or equity of outcomes between or within countries. RESULTS: Serches yielded 2816 documents for assessment. After pre-screening and removal of duplicates, 552 documents underwent detailed evaluation and pertinent information was extracted from 188 unique documents. As a global funding mechanism, GAVI responded rationally to a semi-fixed funding constraint by focusing on between-country equity in allocation of resources. GAVI's predominant focus and documented successes have been in addressing between-country inequities in access to vaccines comparing lower income (GAVI-eligible) countries with higher income (ineligible) countries. GAVI has had mixed results at addressing between-country inequities in utilization of immunization services, and has only more recently put greater emphasis and resources towards addressing within-country inequities in utilization to immunization services. Over time, GAVI has progressively added vaccines to its portfolio. This expansion should have addressed inter-country, inter-regional, inter-generational and gender inequities in disease burden, however, evidence is scant with respect to final outcomes. CONCLUSION: In its next phase of operations, the Alliance can continue to demonstrate its strength as a highly effective multi-partner enterprise, capable of learning and innovating in a world that has changed much since its inception. By building on its successes, developing more coherent and consistent approaches to address inequities between and within countries and by monitoring progress and outcomes, GAVI is well-positioned to bring the benefits of vaccination to previously unreached and underserved communities towards provision of universal health coverage.
Authors: Lieve Goeman; Benedicte Galichet; Denis G Porignon; Peter S Hill; Naima Hammami; Marthe-Sylvie Essengue Elouma; Patrick Y Kadama; Wim Van Lerberghe Journal: Health Policy Plan Date: 2010-02-01 Impact factor: 3.344
Authors: Till Bärnighausen; Seth Berkley; Zulfiqar A Bhutta; David M Bishai; Maureen M Black; David E Bloom; Dagna Constenla; Julia Driessen; John Edmunds; David Evans; Ulla Griffiths; Peter Hansen; Farah Naz Hashmani; Raymond Hutubessy; Dean T Jamison; Prabhat Jha; Mark Jit; Hope Johnson; Ramanan Laxminarayan; Bruce Y Lee; Sharmila Mhatre; Anne Mills; Anders Nordström; Sachiko Ozawa; Lisa Prosser; Karlee Silver; Christine Stabell Benn; Baudouin Standaert; Damian Walker Journal: Lancet Glob Health Date: 2014-04-23 Impact factor: 26.763
Authors: Catherine Arsenault; Sam Harper; Arijit Nandi; José M Mendoza Rodríguez; Peter M Hansen; Mira Johri Journal: Bull World Health Organ Date: 2016-11-21 Impact factor: 9.408
Authors: Mary Bayham; Meridith Blevins; Melanie Lopez; Omo Olupona; Lazaro González-Calvo; Elisée Ndatimana; Ann F Green; Troy D Moon Journal: Am J Trop Med Hyg Date: 2016-11-07 Impact factor: 2.345
Authors: Shellese A Shemwell; Meridith B Peratikos; Lázaro González-Calvo; Montse Renom-Llonch; Alexandre Boon; Samuel Martinho; Charlotte B Cherry; Ann F Green; Troy D Moon Journal: Int Health Date: 2017-07-01 Impact factor: 2.473
Authors: Finn McGuire; Lavanya Vijayasingham; Anna Vassall; Roy Small; Douglas Webb; Teresa Guthrie; Michelle Remme Journal: Global Health Date: 2019-12-18 Impact factor: 4.185
Authors: David FitzSimons; Greet Hendrickx; Johannes Hallauer; Heidi Larson; Daniel Lavanchy; Ina Lodewyckx; Daniel Shouval; John Ward; Pierre Van Damme Journal: Hepatol Med Policy Date: 2016-12-16